Sarcopenia Treatment Market Share Will Hit USD 3.9 by 2030 at a 4% CAGR: Research Report By MarkNtel Advisors

Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Sarcopenia Treatment Market, The Global Sarcopenia Treatment Market size was valued at around USD 3 billion in 2024 and is projected to reach USD 3.9 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 4% during the forecast period, i.e., 2025-30. The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Sarcopenia Treatment Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook & Forecasts:

Forecast Period: 2025-2030
Market Size in 2024: USD 3 Billion
CAGR (2025-2030): 4%

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/sarcopenia-treatment-market.html

Global Sarcopenia Treatment Market Segmentation Breakdown:

By Treatment Type
- Protein Supplements – Market Size & Forecast 2020-2030F, USD Million
- Vitamin B12 Supplements – Market Size & Forecast 2020-2030F, USD Million
- Vitamin D and Calcium Supplements – Market Size & Forecast 2020-2030F, USD Million

According to reports, Protein Supplements are the market leader in the Global Sarcopenia Treatment Market holding almost 50% of the total market because protein supplements directly support muscle health and prevent muscle loss.

By Diagnostic Method
- Biochemical Tests – Market Size & Forecast 2020-2030F, USD Million
- Imaging Techniques – Market Size & Forecast 2020-2030F, USD Million
- Functional Assessments – Market Size & Forecast 2020-2030F, USD Million
- Others – Market Size & Forecast 2020-2030F, USD Million

According to reports, Functional assessments account for around 40% of the Global Sarcopenia Treatment Market.

By Distribution Channel
- Hospital Pharmacies Source – Market Size & Forecast 2020-2030F, USD Million
- Retail Pharmacies Source – Market Size & Forecast 2020-2030F, USD Million
- Online Pharmacies Source – Market Size & Forecast 2020-2030F, USD Million
- Other – Market Size & Forecast 2020-2030F, USD Million

Geographical Growth Insights:

By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

According to reports, North America is the market leader with around 40% share of the market for sarcopenia treatments worldwide because of its aging population, sophisticated healthcare system, and high sarcopenia awareness.

MarkNtel Advisors Highlights Key Market Drivers for Sarcopenia Treatment Market:

Increasing Global Aging Population – The Global Sarcopenia Treatment Market is majorly driven by the growing global aging population. The number of people more than 65 years old globally is projected to increase by double, rising from 761 million in 2021 to at least 1.6 billion in 2050. Due to this demographic trade sarcopenia, a situation that affects a massive percentage of older adults, and other age-associated illnesses are becoming usual. People begin losing nearly 3 to 8 percent of their muscular mass every ten years after the age of 30. Throughout their lives, maximum males will lose roughly 30% of their muscular mass. Sarcopenia has been mentioned to influence up to 15% of people aged between 60 to 70 years and as much as 50% of people over 80 years of age. This lack of muscle is a serious difficulty for older populations because it can result in increased frailty, disability, and a high chance of falls and fractures.

Thus, effective sarcopenia treatment options are becoming more important as the population ages to preserve independence, enhance mobility, and decrease medical charges related to the situation’s complications. Developing information on the sarcopenia affects elderly people is also demanding interventions like medicine, physical remedies, and dietary supplements.

A Comprehensive Analysis of Leading Companies in Global Sarcopenia Treatment Market

Pfizer Inc., Yeast Zydus Cadila, Ltd, Angel Yeast, Makers Nutrition LLC, Metabolic Technologies Inc., Metagenics LLC, Haleon Group of Companies, Abbott Laboratories, Nestlé SA, Eli Lilly, Sanofi Inc., Novartis AG, Amway Corporation, Bayer AG, and Others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/sarcopenia-treatment-market.html

Global Sarcopenia Treatment Industry Recent Development:

July 2024: Abbott Laboratories initiated clinical studies to evaluate the effectiveness of their new protein supplement created specifically for people with sarcopenia. By examining improvements in muscle strength and functionality in older adults, the study aims to support Abbott’s focus on innovative approaches to age-related health problems.
June 2024: Pfizer Inc. declared a partnership with several universities to advance research on sarcopenia. Pfizers dedication to tackling the escalating concerns regarding muscle loss in the elderly population is demonstrated by this partnership which aims to explore the possibilities of novel pharmaceutical therapy in conjunction with nutritional interventions.

What are the growth opportunities driving the Global Sarcopenia Treatment Market?

Collaborations Between Healthcare Providers and Supplement Manufacturers – A notable opportunity in the Sarcopenia Treatment Market lies in the collaboration between healthcare companies and supplement manufacturers. These partnerships can power innovation in the improvement of effective, integrated treatment solutions that integrate scientific expertise with first-rate dietary supplements. The growing recognition of the importance of both medical and dietary interventions in dealing with sarcopenia has brought a shift towards collaborative efforts that propose to provide complete care for older adults. Healthcare companies, along with physicians, geriatricians, and physical therapists, are incorporating dietary guidance into their treatment plans, as protein supplementation and vitamin D can notably slow muscle loss in growing older populations.

Additionally, supplement producers are focusing more on creating customized formulations that address the root causes of sarcopenia such as low energy metabolism and muscle protein breakdown. By working together, the manufacturers are better matching their products with the requirements of healthcare professionals offering patients specialized solutions. Moreover, these collaborations lead to cooperative clinical trials which would reinforce the market’s confidence in sarcopenia treatments and improve the scientific validation of nutritional interventions.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Key Advantages of the Report by MarkNtel Advisors:

Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.

Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.

Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/sarcopenia-treatment-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:

Global Electric Vehicle Motor Market – The Global Electric Vehicle Motor Market size was valued at around USD 46 billion in 2024 and is projected to reach USD 120 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 17% during the forecast period, i.e., 2025-30.

India Logistics Market – The India Logistics Market size was valued at around USD 230 billion in 2024 and is projected to reach USD 360 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8% during the forecast period, i.e., 2025-30.